4//SEC Filing
Lis William 4
Accession 0001213900-22-063936
CIK 0001788028other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 7:58 PM ET
Size
5.0 KB
Accession
0001213900-22-063936
Insider Transaction Report
Form 4
Lis William
DirectorChief Executive Officer
Transactions
- Award
Voting Common Stock
2022-10-12+29,500→ 69,986 total
Footnotes (1)
- [F1]The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001574558
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 7:58 PM ET
- Size
- 5.0 KB